Target trial emulations for tirzepatide, semaglutide and SGLT2-inhibitors for dementia
A recent study indicates that tirzepatide may reduce incident dementia more than semaglutide or SGLT2 inhibitors in adults with type 2 diabetes.
Alzheimer’s risk reduced after high-dose influenza vaccination vs. standard dose, study finds
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic NeuroinflammationAlzheimer'S…
Dementia: Cooking more meals at home per week may help lower risk
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Dementia PreventionLifestyle…
Reading, doing puzzles while sitting may help offset dementia risk
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Dementia PreventionCognitive…
